Suggestions
Michael Burton
Chief Executive Officer
Michael J. Burton is the Chief Executive Officer of the Diabetes Research Institute Foundation (DRIF).1 He is a seasoned nonprofit executive with over 30 years of experience in leading high-impact philanthropic programs and cultivating strategic relationships to secure transformative funding.1
Professional Background
Before joining DRIF, Burton held leadership positions at several prestigious institutions:
- President and CEO of Gateway for Cancer Research
- Chief Development Officer and Executive Director of the Foundation at the American Association for Cancer Research (AACR)
- Senior Vice President and Chief Development Officer at Fox Chase Cancer Center
- Special Assistant to the President at the University of Pennsylvania
- Assistant Dean at Temple University's Fox School of Business
- Legislative and Press Assistant to Congressman Tom Lantos
Education and Expertise
Burton is a graduate of the University of Pennsylvania, where he earned a Bachelor's degree in Communications and a Master's degree in Public Administration.1 His extensive experience spans various sectors, including:
- Cancer research and care
- Higher education
- Nonprofit leadership
- Philanthropic program management
- Strategic relationship building
Leadership Philosophy
Burton is known for his:
- Passion for nonprofit work
- Ability to shape and lead results-oriented organizations
- Commitment to transparency and inclusion
- Inspiration from servant leadership and continuous improvement philosophies1
Current Role at DRIF
As CEO of DRIF, Burton is enthusiastic about the progress and promise in diabetes research.2 He emphasizes the potential for new breakthroughs and the foundation's contributions to understanding and treating diabetes over the past 50 years.2 Under his leadership, DRIF is focusing on areas such as:
- Islet cell transplantation
- Beta cell regeneration
- Understanding the relationship between diabetes and the immune system
Burton is committed to fostering collaboration within the nonprofit world to advance the fight against Type 1 diabetes.2